Aisling Capital as of June 30, 2017
Portfolio Holdings for Aisling Capital
Aisling Capital holds 16 positions in its portfolio as reported in the June 2017 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Loxo Oncology | 57.5 | $336M | 4.2M | 80.19 | |
| Aimmune Therapeutics | 10.5 | $62M | 3.0M | 20.56 | |
| Viewray (VRAYQ) | 8.3 | $48M | 7.5M | 6.47 | |
| Esperion Therapeutics (ESPR) | 6.6 | $39M | 837k | 46.28 | |
| Versartis | 6.0 | $35M | 2.0M | 17.45 | |
| Adma Biologics (ADMA) | 2.3 | $13M | 3.6M | 3.70 | |
| Paratek Pharmaceuticals | 2.0 | $12M | 483k | 24.10 | |
| Syros Pharmaceuticals | 1.4 | $8.2M | 509k | 16.09 | |
| Cidara Therapeutics Inc Common Stock Usd 0.0001 | 1.3 | $7.7M | 1.0M | 7.50 | |
| Transenterix | 1.3 | $7.3M | 10M | 0.71 | |
| Agile Therapeutics | 1.2 | $6.8M | 1.8M | 3.75 | |
| T2 Biosystems | 0.8 | $4.9M | 1.5M | 3.21 | |
| Chimerix (CMRX) | 0.4 | $2.6M | 473k | 5.45 | |
| Pernix Therapeutics Holdings | 0.1 | $844k | 210k | 4.02 | |
| Pernix Therapeutics Hldgs In dbcv 4.250% 4/0 | 0.1 | $775k | 2.5M | 0.31 | |
| Zeltiq Aesthetics | 0.0 | $0 | 12k | 0.00 |
